Skip to main content
. 2022 Dec 27;78(9):860–867. doi: 10.1136/thorax-2022-219642

Figure 3.

Figure 3

HR (95% CI) for each adverse outcome by overall, cumulative OCS exposures, compared with the reference category of non-OCS patients in UK patients with asthma. OCS, oral corticosteroid.